← FDA Drug Approvals (Drugs@FDA)
ACITRETIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS INC · Approved 2015-12-23
Drug application
- FDA Application #
ANDA202552- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ACITRETIN
- Generic name
- ACITRETIN
- Active ingredients
- ACITRETIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- IMPAX LABS INC
- Manufacturer
- Amneal Pharmaceuticals of New York LLC
- First approval
- 2015-12-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown